Akoya Biosciences Inc (AKYA)

13.51 -0.23  -1.67% NASDAQ Dec 8, 11:58 USD

Akoya Biosciences Debt to Equity Ratio:

0.2356 for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Debt to Equity Ratio Chart

Export Data
Save Image
Print Image

Historical Debt to Equity Ratio Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 0.2356
June 30, 2021 0.2182
March 31, 2021 -0.5771
Dec. 31, 2020 1.859

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Benchmarks

Bruker Corp 0.7689
Harvard Bioscience Inc 0.588
NanoString Technologies Inc 1.129

Debt to Equity Ratio Range, Past 5 Years

Minimum -0.5771 Mar 2021
Maximum 1.859 Dec 2020
Average 0.4339


Insider Buy: Akoya Biosciences
MT Newswires 11/19 14:53 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.